Biophysical Characteristics of ATH434, a Unique Iron-Targeting Drug for Treating Friedreich's AtaxiaLikeFollowShareShare your feedbackQuestions (0)Post questionYour question will be sent privately to Alterity Therapeutics. The company may choose to make this question public.Start the conversationAsk Alterity Therapeutics a question about this update.DiscoverShare your feedbackDiscover